I am most grateful to the noble Baroness. The EU knows about our arrangements. The way in which we have set out the market authorisation holders could not be a stronger signal to our European friends that we have found what we think is an appropriate way of ensuring that we have the protections we believe we need. We are not being draconian or difficult; we believe that it is important to have an international trade in good animal medicines. That is what we seek. For those reasons, I will look at Hansard for any other points to address. In the meantime, I commend the regulations to the Committee.
Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019
Proceeding contribution from
Lord Gardiner of Kimble
(Conservative)
in the House of Lords on Wednesday, 27 February 2019.
It occurred during Debates on delegated legislation on Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019.
About this proceeding contribution
Reference
796 c46GC Session
2017-19Chamber / Committee
House of Lords Grand CommitteeSubjects
Librarians' tools
Timestamp
2023-02-03 10:00:09 +0000
URI
http://hansard.intranet.data.parliament.uk/Lords/2019-02-27/190227194000112
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2019-02-27/190227194000112
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2019-02-27/190227194000112